bullish
[Blue Lotus Daily]:981HK/LKNCY US/BGNE US
90 Views18 Jun 2024 16:59
Huawei's new supercomputing center benefits SMIC; Cotti Coffee changes formulas; AstraZeneca's results pose competition for BeiGene.
What is covered in the Full Insight:
- Huawei Wuhu Supercomputing Center and its benefit to SMIC
- Changes in Cotti Coffee's Product Formulas and their potential impact on Luckin Coffee
- AstraZenca's Calquence Phase III results and their implications for BeiGene's Zanubrutinib
- Analysis of data from the Ministry of Industry and Information Technology (MIIT) about China's computing power
- Zanubrutinib's performance and impact on BeiGene's total product revenue
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
Top Quartile
Blue Lotus Research Institute
China growth and global non-US Internet equities
- [Blue Lotus Daily]:981HK/LKNCY US/BGNE US18 Jun 2024
x